Protein in louse intestine ‘offers potential for fish vaccine’ In a doctorate, new general knowledge about the biology of salmon lice has been obtained, but it has also resulted in the discovery of protein in the salmon lice intestine that can potentially be attacked by a vaccine.
Fish farmer reports good experience with PD vaccine The first fish farmer in Europe to use the DNA vaccine Clynav against pancreas disease in salmon has reported positive early results.
Aquaculture vaccines market will surpass $290 million by 2025 New research published by Global Market Insights Inc predicts that the global aquaculture vaccines market will reach $290 million USD by the year 2025.
New prototypes of SRS vaccine developed Scientists in Chile have developed candidates for prototypes of a vaccine against Piscirickettsia salmonis, commonly known as SRS.
Vaccine cuts lice loads by 97% in lab tests Chilean researchers have created a vaccine against sea lice that, in laboratory tests, has shown promising results, reducing the volume of lice by 97%.
New inactivated vaccine against PRV tested Scientists have developed a vaccine against Piscine orthoreovirus (PRV) that has been seen to give effective protection against disease and injuries caused by the pathogen.
Scots companies poised for Aqua Nor showcase Ten Scottish companies are preparing to take part in the first Scottish pavilion at Aqua Nor, the world’s largest aquaculture technology exhibition.
Salmon vaccine doses almost double in April The number of vaccine doses administered to salmon in Norway almost doubled in April, according to the latest figures from aquaculture pharmaceuticals company Pharmaq.
SRS vaccine breakthrough The approval of Pharmaq's vaccine Alpha Ject LiVac SRS by the Chilean authorities should mark an important step in the battle to control Salmon Rickettsial Septicaemia (SRS) syndrome, one of the biggest problems facing the Chilean aquaculture industry.
